Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Gasporox - Catching its breath after a strong H1 2023

Gasporox

Redeye provides an update on Gasporox after its Q3 2023 report. The report came in weaker-than-expected after H1 2023 results exceeding our expectations significantly. While we are pleased by AutoMap already receiving orders worth SEK3m, we have less optimistic Gasporox will manage to grow in H1 2024 due to the strong 2023 results. Thus, we reduce our fair value range while we remain optimistic about the long-term.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Gasporox - Catching its breath after a strong H1 2023

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.